The growing knowledge about the dysfunction of these proteins in Wilson and Menkes diseases should definitely help to determine how Cu and Pt metabolic pathways might be manipulated to suppress ATP7A/B-associated oncogenic processes. The gene discussed is ATP7A; the disease is Menkes disease.